LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Mental Health Pionee | LifeStance Health Group emerges as a key player in outpatient mental health services, with a unique business model less dependent on traditional healthcare reimbursements |
Financial Resilience | Strong Q2 2024 performance led to raised guidance, with revenue up 20.08% over 12 months and stock price surging 47.9% in six months |
Valuation Conundrum | Despite robust growth, LifeStance faces valuation challenges with an EV/EBITDA multiple of 132.99x, sparking mixed analyst opinions and price targets |
Growth vs. Sustainability | Explore LifeStance's strategies for expansion and operational efficiency, balanced against concerns of maintaining momentum and potential margin pressures in FY25 |
Metrics to compare | LFST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFSTPeersSector | |
---|---|---|---|---|
P/E Ratio | −130.0x | −0.6x | −0.5x | |
PEG Ratio | −1.45 | 0.03 | 0.00 | |
Price/Book | 1.4x | 1.3x | 2.6x | |
Price / LTM Sales | 1.6x | 1.0x | 3.3x | |
Upside (Analyst Target) | 57.7% | 40.1% | 38.7% | |
Fair Value Upside | Unlock | 6.3% | 5.0% | Unlock |